Literature DB >> 29927521

What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer?

Srinivasa Reddy Bonam1,2,3, Yuan Seng Wu4, Lakshmi Tunki2, Ranjithkumar Chellian4, Mahabalarao Sampath Kumar Halmuthur2,3, Sylviane Muller1,5, Vijayapandi Pandy4,6.   

Abstract

Several modern treatment strategies have been adopted to combat cancer with the aim of minimizing toxicity. Medicinal plant-based compounds with the potential to treat cancer have been widely studied in preclinical research and have elicited many innovations in cutting-edge clinical research. In parallel, researchers have eagerly tried to decrease the toxicity of current chemotherapeutic agents either by combining them with herbals or in using herbals alone. The aim of this article is to present an update of medicinal plants and their bioactive compounds, or mere changes in the bioactive compounds, along with herbal edibles, which display efficacy against diverse cancer cells and in anticancer therapy. It describes the basic mechanism(s) of action of phytochemicals used either alone or in combination therapy with other phytochemicals or herbal edibles. This review also highlights the remarkable synergistic effects that arise between certain herbals and chemotherapeutic agents used in oncology. The anticancer phytochemicals used in clinical research are also described; furthermore, we discuss our own experience related to semisynthetic derivatives, which are developed based on phytochemicals. Overall, this compilation is intended to facilitate research and development projects on phytopharmaceuticals for successful anticancer drug discovery.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  anticancer; bioactive compounds; edible therapy; medicinal plants; phytochemicals

Mesh:

Substances:

Year:  2018        PMID: 29927521     DOI: 10.1002/cmdc.201800343

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

Review 1.  Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Authors:  Nurul Amirah Mohd Zaid; Mahendran Sekar; Srinivasa Reddy Bonam; Siew Hua Gan; Pei Teng Lum; M Yasmin Begum; Nur Najihah Izzati Mat Rani; Jaishree Vaijanathappa; Yuan Seng Wu; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Drug Des Devel Ther       Date:  2022-01-06       Impact factor: 4.162

Review 2.  Drug-herb combination therapy in cancer management.

Authors:  Urvashi Langeh; Vishal Kumar; Charan Singh; Arti Singh
Journal:  Mol Biol Rep       Date:  2022-09-09       Impact factor: 2.742

3.  An In Vitro Estimation of the Cytotoxicity and Genotoxicity of Root Extract from Leonurus sibiricus L. Overexpressing AtPAP1 against Different Cancer Cell Lines.

Authors:  Przemysław Sitarek; Ewelina Synowiec; Tomasz Kowalczyk; Tomasz Śliwiński; Ewa Skała
Journal:  Molecules       Date:  2018-08-16       Impact factor: 4.411

Review 4.  Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Roman Lysiuk; Antonio Vella; Larysa Lenchyk; Taras Upyr
Journal:  Int J Mol Sci       Date:  2018-11-12       Impact factor: 5.923

5.  Transepithelial Anti-Neuroblastoma Response to Kale among Four Vegetable Juices Using In Vitro Model Co-Culture System.

Authors:  John E Piletz; Yuhan Mao; Debarshi Roy; Bilal Qizilbash; Eurielle Nkamssi; Enleyona Weir; Jessica Graham; Mary Emmanuel; Suwaira Iqbal; Kellie Brue; Bidisha Sengupta
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

6.  P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex.

Authors:  Alessia Garufi; Eugenia Giorno; Maria Saveria Gilardini Montani; Giuseppa Pistritto; Alessandra Crispini; Mara Cirone; Gabriella D'Orazi
Journal:  Biomolecules       Date:  2021-02-25

7.  Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling.

Authors:  Yan Zhang; Pei Ma; Zhiguang Duan; Yannan Liu; Yu Mi; Daidi Fan
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

8.  Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.

Authors:  Nur Sakinah Muhamad Fadzil; Mahendran Sekar; Siew Hua Gan; Srinivasa Reddy Bonam; Yuan Seng Wu; Jaishree Vaijanathappa; Subban Ravi; Pei Teng Lum; Shivsharan B Dhadde
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

Review 9.  Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer.

Authors:  Puvanesswaray Ramakrishnan; Wei Mee Loh; Subash C B Gopinath; Srinivasa Reddy Bonam; Ismail M Fareez; Rhanye Mac Guad; Maw Shin Sim; Yuan Seng Wu
Journal:  Acta Pharm Sin B       Date:  2019-11-14       Impact factor: 11.413

Review 10.  Long Noncoding RNA UCA1 in Gastrointestinal Cancers: Molecular Regulatory Roles and Patterns, Mechanisms, and Interactions.

Authors:  Suaidah Ramli; Maw Shin Sim; Rhanye M Guad; Subash C B Gopinath; Vetriselvan Subramaniyan; Shivkanya Fuloria; Neeraj K Fuloria; Ker Woon Choy; Sohel Rana; Yuan Seng Wu
Journal:  J Oncol       Date:  2021-04-10       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.